Skip to main content
letter
. 2019 Aug 16;30(9):1773–1776. doi: 10.1681/ASN.2019050550

Figure 1.

Figure 1.

Higher doses of ESA are prescribed for patients taking DPO-α (i.e., category 4 and 5) compared with those taking EPO-α/β. The range of ESA doses in each category is based on the dose conversion ratio (EPO/DPO=200).